Comparison of serum concentrations of α-tocopherol and β-carotene in a cross-sectional sample of obese and nonobese children (NHANES III)

Journal of Pediatrics

Volumn 134, Issue 2, 1999, Pages 160-165

  Strauss, Richard S ^a,b  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b UMDMJ Robert Wood Johnson Med S   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; BETA CAROTENE;

ADOLESCENT; ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CHILD; CHOLESTEROL BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; OBESITY; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN BLOOD LEVEL;

EID: 0033025969     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(99)70409-9     Document Type: Article

References (42)

1. 1. Gortmaker SL, Dietz WH, Sobol AM, Wehler CA, Increasing pediatric obesity in the United States. Am J Dis Child 1987;141:535-40.
2. 2. Troiano R, Flegal KM, Kuczmarski RJ, Campbell SM, Johnson CL. Overweight prevalence and trends for children and adolescents. The National Health and Nutrition Examination Surveys 1963 to 1991. Arch Pediatr Adol Med 1995;1085-91.
3. 3. Mossberg HO. 40-year follow-up of overweight children. Lancet 1989;2: 491-3.
4. 4. Must A, Jacques PF, Dallal GE, Bajema CJ, Dietz WH. Long-term morbidity and mortality of overweight adolescents. A follow-up of the Harvard Growth Study of 1922 to 1935. N Engl J Med 1992;327:1350-5.
5. 5. Holman RL, McGill HC Jr, Strong JP, Geer JC. The natural history of atherosclerosis: the early aortic lesions as seen in New Orleans in the middle of the 20th century. Am J Pathol 1958;34:209-35.
6. 6. McGill HC, McMahan CA, Malcolm GT, Oalmann MC, Strong JP. Relation of glycohemoglobin and adiposity to atherosclerosis in youth. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Arterscleros Thromb Vasc Biol 1995; 15:431-40.
7. 7. Berensen GS, Srinivasan SR, Bao W, Newman WP, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. N Engl J Med 1998;338:1650-6.
8. 8. Witztum JL, Steinberg D. Role of oxidized low density lipoprotein in atheroclerosis. J Clin Invest 1991;88: 1785-92.
9. 9. Yla-Herttualo S, Palinski W, Rosenfeld ME, Parthasarathy S, Carew TE, Butler S, et al. Evidence for the presence of oxidatively modified LDL in atherosclerotic lesions of rabbit and man. J Clin Invest 1989;84:1086-95.
10. 10. Regenstrom J, Nilsson J, Tornvall P, Landou C, Hamsten A. Susceptibility of low-density lipoprotem oxidation and coronary atherosclerosis in man. Lancet 1992;339:1183-6.
11. 11. Salonen JT, Yla-Hertuala S, Yamamoto R, Butler S, Korpela H, Salonen R, et al. Autoantibodies against oxidized low density lipoprotein and progression of carotid atherosclerosis. Lancet 1992;339;883-7.
12. 12. Moor de Burgos A, Wartanowics M, Ziemlanski S. Blood vitamin and lipid levels in overweight and obese women. Eur J Clin Nutr 1992;46:803-8.
13. 13. Ohrvall M, Tengblad S, Vessby B. Lower tocopherol serum levels in subjects with abdominal adiposity. J Intern Med 1993;234:53-60.
14. 14. Decsi T, Molnar D, Koletzko B. Reduced plasma concentrations of alphatocopherol and beta-carotene in obese boys. J Pediatr 1997;130:653-5.
15. 15. Must A, Dallai GE, Dietz WH. Reference data for obesity: 85th and 95th percentiles of body mass index and triceps skinfold thickness. Am J Clin Nutr 1991;53:839-46. Erratum: Am J Clin Nutr 1991;54:773.
16. 16. Himes JH, Dietz WH. Guidelines for overweight in adolescent preventive services: recommendations from an expert committee. Am J Clin Nutr 1994;59:307-16.
17. 17. Thurnham DI, Davies JA, Crump BJ, Situnayake RD, Davis M. The use of different lipids to express serum tocopherohlipid ratios for measurement of vitamin E status. Ann Clin Biochem 1986;23:514-20.
18. 18. Horwitt MK, Harvey CC, Dahm CH, Scarcy MT. Relationship between tocopherol and serum lipid levels for determination of nutritional adequacy. Ann NY Acad Sci 1972;203:223-36.
19. 19. Bieri JG, Poukka R, Thorp S. Factors affecting the exchange of tocopherol between red blood cells and plasma. Am J Clin Nutr 1977;30:686-90.
20. 20. Sokol RJ, Balistreri WF. Hoofnagle JH, Jones EA. Vitamin E deficiency in adults with chronic liver disease. Am J Clin Nutr 1985;41:66-72.
21. 21. Westat, Inc. NHANES III dietary interviewer's manual. Prepared for the National Center for Health Statistics. Hyattsville (MD): US Department of Health and Human Services; 1992.
22. 22. Bandini L, Schoeller DA, Cyr HN, Dietz WH. Validity of reported energy intake in obese and nonobese adolescents. Am J Clin Nutr 1990;52:421-5.
23. 23. Lightman SW, Pisarka K, Berman ER, Pestone M, Dowling H, Offentiacher E, et al. Discrepancy between self-reported and actual caloric intake and exercise in obese subjects. N Engl J Med 1992;327:1893-8.
24. 24. Ocke MC, Bueno-de-Mesquita HB, Goddijn HE, Jansen A, Pols MA, van Staveren WA, et al. The Dutch EPIC food frequency questionnaire. I. Description of the questionnaire, and relative validity and reproducibility of food groups. Int J Epidemiol 1997;26(Suppl 1):S37-48.
25. 25. Ascherio A, Stampfer MJ, Colditz GA, Rimm EB, Litin L, Willett WC. Correlations of vitamin A and E intakes with the plasma concentrations of carotenoids and tocopherols among American men and women. J Nutr 1992;122:1792-801.
26. 26. Bieri JG, Poukla Evart R. Effect of plasma lipids levels and obesity on tissue stores of a-tocopherol. Proc Soc Exp Biol Med 1975;149:500-2.
27. 27. Haffner SM, Miettinen H, Stern MP, Agil A, Jialal I. Plasma oxidizability in Mexican-Americans and Non-Hispanic whites. Metabolism 1996;45:876-81.
28. 28. Gey KF, Stahelin HB, Eicholzer M. Poor plasma status of carotene and vitamin C is associated with higher mortality from ischaemic heart disease and stroke. Clin Invest 1993;71:3-6.
29. 29. Morris DL, Kritchevsky SB, Davis CE. Serum carotenoids and coronary heart disease. JAMA 1994;272:1439-41.
30. 30. Greenberg ER, Baron JA, Karagas MR, Stukel TA, Nierenberg DW, Stevens MM, et al. Mortality associated with low plasma concentration of beta carotene and the effect of oral supplementation. JAMA 1996;275:699-703.
31. 31. Esterbauer H, Striegl G, Puhl H, Oberreither S, Rotheneder M, el-Saadani M, et al. The role of vitamin E and carotenoids in preventing oxidation of low density lipoproteins. Ann NY Acad Sci 1989;570:254-67.
32. 32. Carpentert KLH, Veen CVD, Hird R, Dennis IF, Ding T, Mitchinson MJ. The carotenoids β-carotene, canthaxanthin, and zeaxanthin inhibit macrophage-mediated LDL oxidation. FEBS Lett 1997;401:262-6.
33. 33. Oyer Scanlon CE, Berger B, Malcolm G, Wissler RW, PDAY Research Group. Evidence for more extensive deposits of epitopes of oxidized low density lipoprotein in aortas of young people with elevated serum thiocyantate levels. Atherosclerois 1996;121: 23-33.
34. 34. Mosca L, Rubenfire M, Mandel C, Rock C, Tarshis T, Tsai A, et al. Antioxidant nutrient supplementation reduces the susceptibility of low density lipoprotein to oxidation in patients with coronary artery disease. J Am Coll Cardiol 1997;30:392-9.
35. 35. Hininger I, Chopra M, Thurman DI, Laporte F, Richard MJ, Favier A, et al. Effect of increased fruit and vegetable intake on the susceptibility of lipoprotein to oxidation in smokers. Eur J Clin Nutr 1997;51:601-6.
36. 36. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993;328:1450-6.
37. 37. Kushi LH, Folsom AR, Prineas RJ, Mink PJ, Wu Y Bostick YM. Dietary antioxidant vitamins and death from coronary heart disease in post-menopausal women. N Engl J Med 1996;334:1156-62.
38. 38. Stampfer MJ, Henekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption and the risk of coronary heart disease. N Engl J Med 1993;328:1444-9.
39. 39. The Alpha Tocopherol And Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994;330:1019-35.
40. 40. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996;334:1150-5.
41. 41. Hennekens CH, Buring JE, Alanson JE, Stampfer M, Rosner B, Cook NR, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996;334:1145-9.
42. 42. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ. Randomized control trial of vitamin E supplementation in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996;347:1150-5.